Clinical Trials Directory

Trials / Unknown

UnknownNCT01753648

Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Recently, a new and sophisticated method for assessment of retinal blood flow and retinal blood flow velocity profiles has become available. This technique is based on the combination of measurement of retinal vessel calibers with bidirectional Fourier domain optical coherence tomography (FDOCT). The valid measurement of retinal blood flow is of significant importance, because it is known that major ophthalmic diseases, such as hypertensive retinopathy, are associated with alterations in blood flow. Hypertensive retinopathy is the most common manifestation of arterial hypertension in the eye. Elevated systemic blood pressure leads to generalized arteriolar narrowing caused by vasospasms and increased vascular tone. Further in the disease process, focal arteriolar narrowing, retinal haemorrhages, hard exudates and cotton wool spots can occur. Previous studies have shown that blood flow in the extraocular vessels and in the choroid is compromised in patients with arterial hypertension. However, data on the impact of arterial hypertension on retinal blood flow and retinal blood flow velocities are lacking. The present study sets out to compare total retinal blood flow and retinal velocity profiles in patients with hypertensive retinopathy and healthy age- and sex-matched controls. Ocular perfusion pressure will be calculated based on measurements of blood pressure and intraocular pressure to allow for calculation of vascular resistance. In addition, velocity profiles at arterio-venous crossings will be measured. It is hypothesized that these velocity profiles are considerably modified in patients with stage 2 and 3 hypertensive retinopathy compared to healthy controls because of pronounced arterio-venous compression.

Conditions

Interventions

TypeNameDescription
DEVICEDynamic Vessel AnalyzerRetinal vessel diameter, total retinal blood flow (together with FD-OCT), retinal oxygen saturation
OTHERFDOCTtotal retinal blood flow (together with DVA), retinal blood velocities
OTHEROcular perfusion pressureMeasurement of intraocular pressure and mean arterial blood pressure for determination of ocular perfusion pressure

Timeline

Start date
2015-01-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2012-12-20
Last updated
2022-04-07

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01753648. Inclusion in this directory is not an endorsement.